Literature DB >> 17056529

TCRgamma silencing during alphabeta T cell development depends upon pre-TCR-induced proliferation.

Isabel Ferrero1, Stéphane J C Mancini, Frederic Grosjean, Anne Wilson, Luc Otten, H Robson MacDonald.   

Abstract

During thymus development, immature T cells become committed to two distinct lineages based upon expression of alphabeta or gammadelta TCR. In the alphabeta lineage, developing thymocytes progressively extinguish transcription of the TCRgamma genes by a poorly understood process known as gamma silencing. We show that alphabeta lineage thymocytes in mice lacking a functional pre-TCR undergo limited proliferation and fail to silence TCRgamma genes during development. Stimulation of pre-TCR-deficient immature thymocytes with anti-CD3 Abs does not directly down-regulate TCRgamma transcription but restores TCRgamma silencing following proliferation. Collectively our data reveal an important role for pre-TCR induced proliferation in activating the TCRgamma silencer in alphabeta lineage thymocytes, a process that may reinforce alphabeta or gammadelta lineage commitment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056529     DOI: 10.4049/jimmunol.177.9.6038

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Beyond alphabeta/gammadelta lineage commitment: TCR signal strength regulates gammadelta T cell maturation and effector fate.

Authors:  Sandra M Hayes; Renee M Laird; Paul E Love
Journal:  Semin Immunol       Date:  2010-05-08       Impact factor: 11.130

Review 2.  Recent insights into the transcriptional control of the Tcra/Tcrd locus by distant enhancers during the development of T-lymphocytes.

Authors:  Cristina Hernández-Munain
Journal:  Transcription       Date:  2015

3.  Isolation and Ex Vivo Culture of Vδ1+CD4+γδ T Cells, an Extrathymic αβT-cell Progenitor.

Authors:  Christian Welker; Rupert Handgretinger; Karin Schilbach
Journal:  J Vis Exp       Date:  2015-12-07       Impact factor: 1.355

Review 4.  Molecular mechanisms that control mouse and human TCR-alphabeta and TCR-gammadelta T cell development.

Authors:  Tom Taghon; Ellen V Rothenberg
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

Review 5.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.

Authors:  Nicole S D Larmonie; Willem A Dik; Jules P P Meijerink; Irene Homminga; Jacques J M van Dongen; Anton W Langerak
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

Review 6.  Antigen receptor allelic exclusion: an update and reappraisal.

Authors:  Brenna L Brady; Natalie C Steinel; Craig H Bassing
Journal:  J Immunol       Date:  2010-10-01       Impact factor: 5.422

7.  Differential regulation of proximal and distal Vbeta segments upstream of a functional VDJbeta1 rearrangement upon beta-selection.

Authors:  Brenna L Brady; Craig H Bassing
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

8.  Human Peripheral CD4(+) Vδ1(+) γδT Cells Can Develop into αβT Cells.

Authors:  Hendrik Ziegler; Christian Welker; Marco Sterk; Jan Haarer; Hans-Georg Rammensee; Rupert Handgretinger; Karin Schilbach
Journal:  Front Immunol       Date:  2014-12-17       Impact factor: 7.561

Review 9.  Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts.

Authors:  Oxana Dobrovinskaya; Iván Delgado-Enciso; Laura Johanna Quintero-Castro; Carlos Best-Aguilera; Rocío Monserrat Rojas-Sotelo; Igor Pottosin
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

10.  The TCR ligand-inducible expression of CD73 marks γδ lineage commitment and a metastable intermediate in effector specification.

Authors:  Francis Coffey; Sang-Yun Lee; Terkild B Buus; Jens-Peter Holst Lauritsen; Gladys W Wong; Michelle L Joachims; Linda F Thompson; Juan Carlos Zúñiga-Pflücker; Dietmar J Kappes; David L Wiest
Journal:  J Exp Med       Date:  2014-02-03       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.